Clinical Trials Search
Clinical Trial 17753
Study Type: Treatment
Phase of Study: NA
- Julio Pow-Sang
Focal Prostate Radio-Frequency Ablation for the Treatment of Prostate Cancer
The main purpose of this study is to evaluate the safety and efficacy of focal (targeted) Radio-Frequency Ablation (RFA) in men with low or intermediate-risk, clinically localized prostate cancer.
Primary Objective: To assess the local oncologic efficacy of focal RFA in men with unilateral, clinically localized prostate cancer as measured by the ability to obtain all negative biopsy cores at the sites of focal ablation of the cancer, "all negative" means no prostate cancer; if the biopsy contains inflammation, or pre-cancerous changes (high-grade prostatic intraepithelial neoplasia and /or atypical small acinar proliferation it will be considered negative for study purposes). Secondary Objective: To evaluate the safety of the procedure and change in quality-of-life indicators from baseline to 6 months following focal RFA in patients with localized prostate cancer. To understand and evaluate imaging characteristics of treated prostate cancer by bipolar RFA.